INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
13/02/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
THINC-IT
ST13
US500000079213637Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Localização atual
Titulares
Representantes
Maren C. Perry King & Spalding LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
[ Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, cognitive impairment, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; medical diagnostic agents, reagents, preparations and substances for medical purposes; pharmaceutical preparations for treatment of cognitive disorders and diseases ]
Classe 9
Downloadable electronic publications in the nature of [ books, reports, ] brochures, [ booklets, ] leaflets, including patient information leaflets, [ magazines, journals, ] teaching and educational material in the field of research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention [ ; computer application software for mobile devices, namely, software for providing information and interaction in the field research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention ]
Classe 10
[ Medical diagnostic apparatus and instruments for use in diagnosing, managing, monitoring, assessing, controlling and examining symptoms, signs and effects of Alzheimer's disorder and disease, stroke, depression, cognitive impairment, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, collecting, storing, monitoring, assessing, controlling and examining patient data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems ]
Classe 42
[ Pharmaceutical research and development; scientific and technological services, namely, research in the field of medical disorders, diseases, treatment and prevention; scientific and technological services, namely, research in the field of the central nervous system and central nervous system related disorders, diseases and pharmaceuticals; medical research and tests in the field of psychology and neurology; conducting clinical research and tests in the field of psychology and neurology; medical diagnostic research and tests namely, conducting clinical trials for others ]
Classe 44
[ Medical services, therapeutic services and healthcare services, namely, clinical healthcare services; providing medical and healthcare information; services in the field of psychiatry and psychology and medical treatment of central nervous system diseases and disorders; medical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing medical and medicinal information in the field of diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; providing on-line medical data and analyses designed to provide patients and clients customized information, namely, regarding calculation of medical dose, diagnosis, and therapeutic issues and medical management ]
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
13/02/2026
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
13/06/2025
REGISTERED - PARTIAL SEC 71 ACCEPTED
13/06/2025
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13/05/2025
TEAS SECTION 71 RECEIVED
15/01/2025
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/03/2024
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/03/2024
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/03/2024
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22/03/2024
TEAS CHANGE OF OWNER ADDRESS RECEIVED
22/03/2024
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
17/07/2023
FINAL DECISION TRANSACTION PROCESSED BY IB
16/11/2018
FINAL DISPOSITION NOTICE SENT TO IB
29/10/2018
FINAL DISPOSITION PROCESSED
29/10/2018
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/10/2018
REGISTERED-PRINCIPAL REGISTER
17/07/2018
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/05/2018
PUBLISHED FOR OPPOSITION
01/05/2018
NOTIFICATION PROCESSED BY IB
27/04/2018
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/04/2018
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/04/2018
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/04/2018
ELECTRONIC RECORD REVIEW COMPLETE
26/03/2018
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
23/03/2018
APPROVED FOR PUB - PRINCIPAL REGISTER
20/03/2018
EXAMINER'S AMENDMENT ENTERED
20/03/2018
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/03/2018
EXAMINERS AMENDMENT E-MAILED
20/03/2018
EXAMINERS AMENDMENT -WRITTEN
20/03/2018
TEAS/EMAIL CORRESPONDENCE ENTERED
23/02/2018
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/02/2018
ASSIGNED TO LIE
22/02/2018
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/02/2018
REFUSAL PROCESSED BY IB
01/09/2017
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
15/08/2017
REFUSAL PROCESSED BY MPU
14/08/2017
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/08/2017
APPLICATION FILING RECEIPT MAILED
11/08/2017
NON-FINAL ACTION WRITTEN
10/08/2017
ASSIGNED TO EXAMINER
07/08/2017
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/08/2017
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/08/2017
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/08/2017
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.